Skip to main content
Log in

Antioxidant effects of tocotrienols in patients with hyperlipidemia and carotid stenosis

  • Symposium
  • Published:
Lipids

Abstract

Antioxidants may have a role in the prevention of atherosclerosis. In the present trial, we investigated the antioxidant properties of Palm Vitee, a γ-tocotrienol-, and α-tocopherol enriched fraction of palm oil, in patients with carotid atherosclerosis. Serum lipids, fatty acid peroxides, platelet aggregation, and carotid artery stenosis were measured over an 18-month period in fifty patients with cerebrovascular disease. Change in stenosis was measured with duplex ultrasonography. Ultrasound scans were done at six months, twelve months, and yearly thereafter. Bilateral duplex ultrasonography revealed apparent carotid atherosclerotic regression in seven and progression in two of the 25 tocotrienol patients, while none of the control group exhibited regression and ten of 25 showed progression (P<0.002). Serum thiobarbituric acid reactive substances, anex vivo indicator of maximal platelet peroxidation, decreased in the treatment group from 1.08±0.70 to 0.80±0.55 μM/L (P<0.05) after 12 mon, and in the placebo group, they increased nonsignificantly from 0.99±0.80 to 1.26±0.54 μM/L. Both tocotrienol and placebo groups displayed significantly attenuated collagen-induced platelet aggregation responses (P<0.05) as compared with entry values. Serum total cholesterol, low density lipoprotein cholesterol, and triglyceride values remained unchanged in both groups, as did the plasma high density lipoprotein cholesterol values. These findings suggest that antioxidants, such as tocotrienols, may influence the course of carotid atherosclerosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

HDL:

high density lipoprotein

LDL:

low density lipoprotein

TBARS:

thiobarbituric acid reactive substances

References

  1. Salonen, J.T., Yla-Herttuala, S., Yamamoto, R., Butler, S., Korpella, H., Salonen, R., Nyyssonen, K., Palinski, W., and Witztum, J.L. (1992) Autoantibody Against Oxidized LDL and Progression of Carotid Atherosclerosis,Lancet 339, 883–887.

    Article  PubMed  CAS  Google Scholar 

  2. Witztum, J.L., and Steinberg, D. (1991) Role of Oxidized Low Density Lipoprotein in Atherogenesis,J. Clin. Invest. 88, 1785–1792.

    Article  PubMed  CAS  Google Scholar 

  3. Steinberg, D., and Workshop Participants (1992) Antioxidants in the Prevention of Atherosclerosis,Circulation 85, 2338–2344.

    Google Scholar 

  4. Esterbauer, H., Dieber-Rotheneder, M., Striegel, G., and Waeg, G. (1991) Role of Vitamin E in Preventing the Oxidation of Low-Density Lipoprotein,Am. J. Clin Nutr. 3, 314S-321S.

    Google Scholar 

  5. Carew, T.E., Schwenke, D.C., and Steinberg, D. (1987) Antiatherogenic Effect of Probucol Unrelated to Its Hypocholesterolemic Effect: Evidence That Antioxidantsin vivo Can Selectively Inhibit Low Density Lipoprotein Degradation in Macrophage-Rich Fatty Streaks Slowing the Progression of Atherosclerosis in the WHHL Rabbit,Proc. Natl. Acad. Sci. (USA) 84, 7725–7729.

    Article  CAS  Google Scholar 

  6. Mao, S.J.T., Yates, M.T., Parker, R.A., Chi, E.M., and Jackson, R.L. (1991) Attenuation of Atherosclerosis in a Modified Strain of Hypercholesterolemic Watanabe Rabbit with Use of a Probucol Analogue (MD29,311) That Does Not Lower Serum Cholesterol,Arterioscl. and Thromb. 11, 1266–1275.

    CAS  Google Scholar 

  7. Rimm, E.B., Stampfer, M.J., Ascherio, A., Giovanucci, E., Colditz, G.A., and Willett, W.C. (1993) Vitamin E Consumption and the Risk of Coronary Heart Disease in Men,N. Engl. J. Med. 328, 1450–1456.

    Article  PubMed  CAS  Google Scholar 

  8. Stampfer, M.J., Hennekens, C.H., Manson, J.E., Colditz, G.A., Rosner, B., and Willett, W.C. (1993) Vitamin E and Risk of Coronary Disease in Women (1993),N. Eng. J. Med. 328, 1444–1449.

    Article  CAS  Google Scholar 

  9. Gey, K.F. (1995) Ten-Year Retrospective on the Antioxidant Hypothesis of Arteriosclerosis,J. Nutr. Biochem. 6, 206–236.

    Article  CAS  Google Scholar 

  10. Manson, J.E., Stampfer, M.J., Willett, W.C., Colditz, G.A., Speizer, F.E., and Hennekens, C.H. (1995) Antioxidant Vitamin Consumption and Incidence of Stroke in Women,New Engl. J. Med., 23, November, in press.

  11. Pandey, D., Shekelle, R., Tangney, C., and Stamler, J. (1995) Vitamin C and β-Carotene and Risk of Death in Middle-Aged Men in the Western Electric Study,Am. J. Epidem., in press.

  12. Kritchevsky, S.B., Shimakawa, T., Dennis, B., Eckfeldt, J., Carpenter, M., and Heiss, G. (1993) Dietary Antioxidants and Carotid Artery Wall Thickness: ARIC Study,Circulation 87, 3.

    Google Scholar 

  13. Delong, D.M., Delong, R., Wood, P.D., Lippel, K., and Rifkind, B.M. (1986) A Comparison of Methods for the Estimation of Plasma Low- and Very Low-Density Lipoprotein Cholesterol,J. Am. Med. Assoc. 256, 2372–2377.

    Article  CAS  Google Scholar 

  14. Ohishi, N., Ohkawa, H., Miike, A., Tatano, T., and Yagi, K. (1985) A New Assay Method for Lipid Peroxides Using a Methylene Blue Derivative,Biochem. Intl. 10, 205–211.

    CAS  Google Scholar 

  15. Mihara, M., Uchiyama, M., and Fukuzawa, K. (1980) Thiobarbituric Acid Value on Fresh Homogenate of Rat as a Parameter of Lipid Peroxidation in Aging; CCl4 Intoxication and Vitamin E Deficiency,Biochem. Med. 23, 302–311.

    Article  PubMed  CAS  Google Scholar 

  16. Bieri, J.G., Tolliver, T.J., and Catigniani, C.L. (1979) Simultaneous Determination of α-Tocopherol and Retinol in Plasma and Red Cells by High Pressure Liquid Chromatography,Am. J. Clin. Nutri. 32, 2143–2149.

    CAS  Google Scholar 

  17. Galvez, A., Badimon, L., Badimon, J., and Fuster, V. (1986) Electrical Aggregometry in Whole Blood from Human, Pig, and Rabbit,Thromb. and Hem. 56, 128–132.

    CAS  Google Scholar 

  18. Salonen, J.T., Nyssonen, K., Parviainen, M., Kantola, M., Kantola, M., Korpela, H., and Solonen, R. (1993) Low Plasma β-Carotene, Vitamin E and Selenium Levels Associated with Accelerated Carotid Atherogenesis in Hypercholesterolemic Finnish Men,Circulation 87, 2.

    Google Scholar 

  19. Bierenbaum, M.L., Reichstein, R.P., Bhagavan, H.N., and Watkins, T.R. (1992) Relationship Between Serum Lipid Peroxidation Products in Hypercholesterolemic Subjects and Vitamin E Status,Biochem. Int. 28, 57–66.

    PubMed  CAS  Google Scholar 

  20. Qureshi, A.A., Qureshi, N., Hasler-Rapacz, J.O., Weber, F.E., Chaudhary, V., Crenshaw, T.D., Gapor, A., Ong, A.S.H., Chong, Y.H., Peterson, D., and Rapacz, J. (1991) Dietary Tocotrienols Reduce Concentrations of Plasma Cholesterol, Apolipoprotein B, Thromboxane B2 and Platelet Factor 4 in Pigs with Inherited Hyperlipidemias,Am. J. Clin. Nutr. 53, 1042S-1049S.

    PubMed  CAS  Google Scholar 

  21. Qureshi, A.A., Qureshi, N., Wright, J.J.K., Shen, Z., Kramer, G., Gapor, A., Chong, Y.H., Dewitt, G., Ong, A.S.H., Peterson, D.M., and Bradlow, B.A. (1991) Lowering of Serum Cholesterol in Hypercholesterolemic Humans by Palmvitee,Am. J. Clin. Nutr. 53, 1021S-1026S.

    PubMed  CAS  Google Scholar 

  22. Wahlquist, M., Krivokuca-Bogetic, Z., Lo, C.S., Hoge, B., Smith, R., and Lukito, W. (1992) Differential Serum Responses of Tocopherols and Tocotrienols During Vitamin Supplementation in Hypercholesterolemic Individuals Without Change in Coronary Risk Factors,Nutr. Res. 12, S181-S201.

    Article  Google Scholar 

  23. Watkins, T.R., Lenz, P., Gapor, A., Struck, M., Tomeo, A., and Bierenbaum, M.L. (1993) γ-Tocotrienol as a Hypocholesterolemic and Antioxidant Agent in Rats Fed Atherogenic Diets,Lipids 28, 1113–1118.

    Article  PubMed  CAS  Google Scholar 

  24. Bierenbaum, M.L., Fleischman, A.I., Raichelson, R.I., Hayton, T., and Watson, P.B. (1973) Ten-Year Experience of Modified-Fat Diets on Younger Men with Coronary Heart Disease,Lancet 2, 1404–1407.

    Article  Google Scholar 

  25. Miettinen, T.A., Huttunen, J.K., Naukkaunien, V., Strandberg, T., and Vanhanen, H. (1986) Long-Term Use of Probucol in the Multifactorial Primary Prevention of Vascular Disease,Am. J. Card. 57, 49H-54H.

    Article  PubMed  CAS  Google Scholar 

  26. Bocan, T.M.A., Mazur, M.J., Mueller, S.B., Charlton, G., Kieft, K.A., and Krause, B.R. (1994) Atherosclerotic Lesion Development in Hypercholesterolemic Japanese Quail Following Probucol Treatment: A Biochemical and Morphological Evaluation,Pharmacol. Res. 29, 65–76.

    Article  PubMed  CAS  Google Scholar 

  27. Johansson, J., Olsson, A., Bergstrand, L., Elinder, L.S., Nilsson, S., Erikson, U., Molgaard, J., Holme, I., and Waldius, G. (1995) Lowering of HDL2b by Probucol Partly Explains the Failure of the Drug to Affect Femoral Atherosclerosis in Subjects with Hypercholesterolemia,Arterio. Vasc. Biol. 15, 1049–1056.

    CAS  Google Scholar 

  28. Atkins, D., Psaty, B.M., Koepsell, T.D., Longstreth, W.T., and Larson, E.B. (1993) Cholesterol Reduction and the Risk of Stroke in Men. A Meta-Analysis of Randomized, Controlled Trials,Ann. Intern. Med. 119, 136–145.

    PubMed  CAS  Google Scholar 

  29. Herbert, P.R., Gaziano, J.M., and Hennekens, C.H. (1995) An Overview of Trials of Cholesterol Lowering and Risk of Stroke,Arch. Int. Med. 155, 50–55.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

About this article

Cite this article

Tomeo, A.C., Geller, M., Watkins, T.R. et al. Antioxidant effects of tocotrienols in patients with hyperlipidemia and carotid stenosis. Lipids 30, 1179–1183 (1995). https://doi.org/10.1007/BF02536621

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02536621

Keywords

Navigation